Information about ENDO 2013


News and updates about ENDO 2013: The Endocrine Society 95th Annual Meeting & Scientific Expo.

ENDO 2013: The Endocrine Society 95th Annual Meeting & Scientific Expo

June 15-18, 2013

San Francisco, CA

ENDO 2013 will be held at the Moscone Center in San Francisco, CA.

Planning your meeting

Visit the main ENDO 2013 website to access the latest news and updates about the conference.

The complete schedule for ENDO 2013 is available online. You can also browse the conference schedule by day (June 14, June 15, June 16, June 17, June 18) or by program/session type.

Abstracts of oral presentations, posters, and featured poster presentations are also available online.

Special events scheduled for ENDO 2013 include:

  • Free Career Development Workshops (scheduled for June 15-18)
  • The free IDEAL Learning Center: Maintaining the Pace in Androgen Deficiency: Improving the Diagnosis and Management of Hypogonadism (scheduled for June 15-17)
  • “Living Your Best Life with Diabetes” A Special Symposium for Patients (scheduled for Saturday, June 15)
  • The Androgen Deficiency Syndrome in Men MOC Live Learning Session (June 16)
  • The New Light on GPCRs in the Pathophysiology of Diabetes and Metabolic Disorders forum (June 18)

Click here for a complete listing of conference events.

The ENDOExpo is “the place for attendees to learn about cutting-edge advances in science and technology, as well as meet with medical liasions to learn about the latest treatment therapies.” The Expo features “exhibits, poster presentations, food stations, a relaxation station, and areas to meet with colleagues, including ENDO Connect.”

Access the Expo floor plan here.

Recent Videos
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Veeral Sheth, MD: Assessment of EYP-1901 Supplemental Injection Use in Wet AMD | Image Credit: University Retina
HCPLive Five at ADA 2024 | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.